SCHEMBL5999099

SCHEMBL5999099

Cc1nc(C(=O)Nc2cccc(Cl)c2Cl)c(C)n1-c1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 5/20 0.65
CNR2 P34972 5/20 0.65
GRM5 P41594 8/20 0.57
HTR2A P28223 4/20 0.56
HTR2C P28335 4/20 0.56
SLC6A4 P31645 4/20 0.56
HTR1A P08908 2/20 0.56
DRD2 P14416 2/20 0.56
HTR7 P34969 2/20 0.56
DRD3 P35462 2/20 0.56
HTR6 P50406 2/20 0.56
DRD4 P21917 1/20 0.56
KCNH2 Q12809 1/20 0.54
POLB P06746 1/20 0.53
MAPT P10636 2/20 0.48
MEN1 O00255 1/20 0.48
NPC1 O15118 1/20 0.48
LMNA P02545 1/20 0.48
HPGD P15428 1/20 0.48
RAB9A P51151 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16404237 0.87 HTR2A (0.59) CNR1CNR2HTR2AHTR2CSLC6A4
SCHEMBL16404204 0.83 CNR1 (0.67) CNR1CNR2GRM5MAPTNPC1
SCHEMBL16404206 0.82 CNR1 (0.60) CNR1CNR2GRM5HTR2AHTR2C
SCHEMBL2033217 0.79 CNR1 (0.65) CNR1CNR2GRM5MAPTLMNA
SCHEMBL16404225 0.78 CNR2 (0.56) CNR1CNR2MAPTMEN1NPC1
SCHEMBL16404257 0.77 CNR1 (0.60) CNR1CNR2GRM5MAPTMEN1
SCHEMBL16404261 0.73 CNR1 (0.60) CNR1CNR2GRM5HTR2AHTR2C
SCHEMBL3684239 0.73 CNR1 (0.57) CNR1CNR2GRM5MAPTMEN1
SCHEMBL1078744 0.73 HTR2A (1.00) HTR2AHTR2CSLC6A4HTR1ADRD2
SCHEMBL16404252 0.73 CNR1 (0.57) CNR1CNR2GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8937184-B2 1H-imidazole derivatives as cannabinoid CB2 receptor modulators ABBVIE B.V. (NL) 2015-01-20 US disclosed
US-8937184-B2 1H-imidazole derivatives as cannabinoid CB2 receptor modulators ABBVIE B.V. (NL) 2015-01-20 US disclosed
US-8937184-B2 1H-imidazole derivatives as cannabinoid CB2 receptor modulators ABBVIE B.V. (NL) 2015-01-20 US disclosed
US-20060194779-A1 1H-imidazole derivatives as cannabinoid CB2 receptor modulators ABBVIE B.V. (NL) 2006-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194779-A1 1H-imidazole derivatives as cannabinoid CB2 receptor modulators CNR1, CNR2, HRH4 CNR1 1/4885CNR2 2/4885GRM5 309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.